Author:
Higuchi Yujiro,Ando Masahiro,Yoshimura Akiko,Hakotani Satoshi,Koba Yuki,Sakiyama Yusuke,Hiramatsu Yu,Tashiro Yuichi,Maki Yoshimitsu,Hashiguchi Akihiro,Yuan Junhui,Okamoto Yuji,Matsuura Eiji,Takashima Hiroshi
Abstract
AbstractThe presence of fragile X mental retardation 1 (FMR1) premutation has been linked to patients with a certain type of cerebellar ataxia, the fragile X-associated tremor/ataxia syndrome (FXTAS). However, its prevalence in Japan has yet to be clarified. The aim of the present study is to determine the prevalence of FXTAS in Japanese patients with cerebellar ataxia and to describe their clinical characteristics. DNA samples were collected from 1328 Japanese patients with cerebellar ataxia, referred for genetic diagnosis. Among them, 995 patients with negative results for the most common spinocerebellar ataxia subtypes were screened for FMR1 premutation. Comprehensive clinical and radiological analyses were performed for the patients harbouring FMR1 premutation. We herein identified FMR1 premutation from one female and two male patients, who satisfied both clinical and radiological criteria of FXTAS (0.3%; 3/995) as well. Both male patients presented with high signal intensity of corticomedullary junction on diffusion-weighted magnetic resonance imaging, a finding comparable to that of neuronal intranuclear inclusion disease. The female patient mimicked multiple system atrophy in the early stages of her disease and developed aseptic meningitis with a suspected immune-mediated mechanism after the onset of FXTAS, which made her unique. Despite the lower prevalence rate in Japan than the previous reports in other countries, the present study emphasises the necessity to consider FXTAS with undiagnosed ataxia, regardless of men or women, particularly for those cases presenting with similar clinical and radiological findings with multiple system atrophy or neuronal intranuclear inclusion disease.
Funder
ministry of health, labour and welfare
japan agency for medical research and development
japan society for the promotion of science
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,Neurology
Reference51 articles.
1. Cabal-Herrera AM, Tassanakijpanich N, Salcedo-Arellano MJ and Hagerman RJ. Fragile X-associated tremor/ataxia syndrome (FXTAS): pathophysiology and clinical implications. Int J Mol Sci. 2020;21(12). https://doi.org/10.3390/ijms21124391
2. Hall DA, Birch RC, Anheim M, Jonch AE, Pintado E, O’Keefe J, et al. Emerging topics in FXTAS. J Neurodev Disord. 2014;6(1):31. https://doi.org/10.1186/1866-1955-6-31.
3. Jacquemont S, Leehey MA, Hagerman RJ, Beckett LA, Hagerman PJ. Size bias of fragile X premutation alleles in late-onset movement disorders. J Med Genet. 2006;43(10):804–9. https://doi.org/10.1136/jmg.2006.042374.
4. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene–and implications for the population genetics of the fragile X syndrome. Am J Hum Genet. 1995;57(5):1006–18.
5. Otsuka S, Sakamoto Y, Siomi H, Itakura M, Yamamoto K, Matumoto H, et al. Fragile X carrier screening and FMR1 allele distribution in the Japanese population. Brain Dev. 2010;32(2):110–4. https://doi.org/10.1016/j.braindev.2008.12.015.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献